Powell đã tham dự sự kiện của Ban Tài chính Quốc tế của Fed: tưởng nhớ Fischer, nhắc lại tầm quan trọng của nghiên cứu kinh tế toàn cầu và không thảo luận về triển vọng chính sách

Hygea Medical Technology

company

About

Hygea Medical Technology is a oncology-focused biopharma company.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$28M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Hygea Medical Technology is a oncology-focused biopharma company. Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$28M ¥100M
Hygea Medical Technology has raised a total of $28M ¥100M in funding over 2 rounds. Their latest funding was raised on Feb 15, 2023 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 15, 2023 Series D ¥100M 1 Detail
Dec 6, 2019 Series B $28M 2 Jianxing Medical Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Hygea Medical Technology is funded by 3 investors. Jianxing Medical Fund and Gaorong Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Jianxing Medical Fund Yes Series B
Gaorong Capital Series D
Kunying Capital Series B